médecine/sciences,
Journal Year:
2023,
Volume and Issue:
39(2), P. 119 - 128
Published: Feb. 1, 2023
L’odorat,
sens
pendant
longtemps
sous-estimé
chez
l’homme,
a
été
mis
sur
le
devant
de
la
scène
par
sa
soudaine
disparition,
survenue
pandémie
Covid-19,
dont
l’anosmie
est
un
des
symptômes
majeurs.
Pourtant,
depuis
longtemps,
les
virus
respiratoires
ont
associés
aux
troubles
l’odorat,
25
%
seraient
liés
à
une
infection
virale.
L’olfaction
débute
dans
nez,
au
sein
d’un
épithélium
olfactif
qui
particularité
contenir
neurones
en
contact
direct
avec
l’environnement.
Plusieurs
sont
connus
pour
leur
capacité
réplicative
cet
épithélium.
C’est
notamment
cas
du
grippe
(
influenza
)
et
bronchiolite
(VRS,
respiratoire
syncytial),
mais
tropisme
ce
tissu
bien
moindre
que
celui
SARS-CoV-2.
La
physiopathologie
cavité
nasale
permis
commencer
comprendre
liens
existant
entre
virale
l’olfaction.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: July 26, 2023
Abstract
Anosmia
was
identified
as
a
hallmark
of
COVID-19
early
in
the
pandemic,
however,
with
emergence
variants
concern,
clinical
profile
induced
by
SARS-CoV-2
infection
has
changed,
anosmia
being
less
frequent.
Here,
we
assessed
clinical,
olfactory
and
neuroinflammatory
conditions
golden
hamsters
infected
original
Wuhan
strain,
its
isogenic
ORF7-deletion
mutant
three
variants:
Gamma,
Delta,
Omicron/BA.1.
We
show
that
animals
develop
variant-dependent
disease
including
anosmia,
ORF7
contributes
to
induction
dysfunction.
Conversely,
all
are
neuroinvasive,
regardless
presentation
they
induce.
Taken
together,
this
confirms
neuroinvasion
independent
phenomena
upon
infection.
Using
newly
generated
nanoluciferase-expressing
SARS-CoV-2,
validate
pathway
major
entry
point
into
brain
vivo
demonstrate
vitro
travels
retrogradely
anterogradely
along
axons
microfluidic
neuron-epithelial
networks.
Physiological Reviews,
Journal Year:
2023,
Volume and Issue:
103(4), P. 2759 - 2766
Published: June 21, 2023
Anosmia,
the
loss
of
sense
smell,
is
one
main
neurological
manifestations
COVID-19.
Although
SARS-CoV-2
virus
targets
nasal
olfactory
epithelium,
current
evidence
suggests
that
neuronal
infection
extremely
rare
in
both
periphery
and
brain,
prompting
need
for
mechanistic
models
can
explain
widespread
anosmia
COVID-19
patients.
Starting
from
work
identifying
non-neuronal
cell
types
are
infected
by
system,
we
review
effects
these
supportive
cells
epithelium
brain
posit
downstream
mechanisms
through
which
smell
impaired
We
propose
indirect
contribute
to
altered
system
function
COVID-19-associated
anosmia,
as
opposed
or
neuroinvasion
into
brain.
Such
include
tissue
damage,
inflammatory
responses
immune
infiltration
systemic
circulation
cytokines,
downregulation
odorant
receptor
genes
sensory
neurons
response
local
signals.
also
highlight
key
unresolved
questions
raised
recent
findings.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 15, 2024
Abstract
Neutrophil
elastase
(NE)
is
a
proteolytic
enzyme
released
extracellular
during
the
formation
of
neutrophil
traps
(NETs)
through
degranulation.
In
addition
to
participating
in
body's
inflammatory
response,
NE
also
plays
an
important
role
cancer.
It
can
promote
tumor
proliferation,
migration,
and
invasion,
induce
epithelial-mesenchymal
transition
(EMT),
change
microenvironment
(TME)
progression.
Concurrently,
promotes
systemic
treatment
resistance
by
inducing
EMT.
However,
it
selectively
kill
cancer
cells
attenuate
development.
Sivelestat
specific
inhibitor
that
be
used
perioperative
period
esophageal
patients
reduce
incidence
postoperative
complications
after
esophagectomy.
addition,
combination
sivelestat
trastuzumab
enhance
efficacy
human
epidermal
growth
factor
receptor
2(HER
2)
positive
breast
patients.
Meanwhile,
targeting
antibody
domains
fragments
new
way
treat
inflammation-related
diseases.
This
review
provides
valuable
insights
into
treatment.
Additionally,
we
discuss
challenges
associated
with
clinical
application
sivelestat.
By
shedding
light
on
promising
potential
NE,
this
contributes
advancement
strategies.
Neuropathology and Applied Neurobiology,
Journal Year:
2024,
Volume and Issue:
50(2)
Published: Feb. 28, 2024
Olfactory
dysfunction
is
one
of
the
most
common
symptoms
COVID-19.
In
first
2
years
pandemic,
it
was
frequently
reported,
although
its
incidence
has
significantly
decreased
with
emergence
Omicron
variant,
which
since
become
dominant
viral
strain.
Nevertheless,
many
patients
continue
to
suffer
from
persistent
dysosmia
and
dysgeusia,
making
COVID-19-associated
olfactory
an
ongoing
health
concern.
The
proposed
pathogenic
mechanisms
are
complex
likely
multifactorial.
While
evidence
suggests
that
infection
sustentacular
cells
associated
mucosal
inflammation
may
be
culprit
acute,
transient
smell
loss,
alterations
in
other
components
system
(e.g.,
receptor
neuron
dysfunction,
bulb
injury
cortex)
lead
persistent,
long-term
dysfunction.
This
review
aims
provide
a
comprehensive
summary
epidemiology,
clinical
manifestations
current
understanding
Cellular and Molecular Immunology,
Journal Year:
2023,
Volume and Issue:
21(2), P. 134 - 143
Published: Dec. 25, 2023
Abstract
Numerous
pathogens
can
infect
the
olfactory
tract,
yet
pandemic
caused
by
SARS-CoV-2
has
strongly
emphasized
importance
of
mucosa
as
an
immune
barrier.
Situated
in
nasal
passages,
is
directly
exposed
to
environment
sense
airborne
odorants;
however,
this
also
means
it
serve
a
direct
route
entry
from
outside
world
into
brain.
As
result,
olfactotropic
infections
have
serious
consequences,
including
dysfunction
system,
CNS
invasion,
dissemination
lower
respiratory
and
transmission
between
individuals.
Recent
research
shown
that
distinctive
response
needed
protect
neuronal
mucosal
tissue.
A
better
understanding
innate,
adaptive,
structural
barriers
develop
effective
therapeutics
vaccines
against
microbes
such
SARS-CoV-2.
Here,
we
summarize
ramifications
infection
mucosa,
review
subsequent
response,
discuss
important
areas
future
for
immunity
infectious
disease.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4460 - 4460
Published: April 18, 2024
Chronic
rhinosinusitis
(CRS)
is
a
highly
prevalent
disease
and
up
to
83%
of
CRS
patients
suffer
from
olfactory
dysfunction
(OD).
Because
OD
specifically
seen
in
those
that
present
with
type
2
eosinophilic
inflammation,
it
believed
inflammatory
mediators
at
the
level
epithelium
are
involved
development
this
loss.
However,
due
difficulties
obtaining
tissue
epithelium,
little
known
about
true
mechanisms
OD.
Thanks
COVID-19
pandemic,
interest
olfaction
has
been
growing
rapidly
several
studies
have
focusing
on
conditions.
In
paper,
we
summarize
most
recent
data
exploring
pathophysiological
underlying
CRS.
We
also
review
what
potential
capacity
recovery
currently
available
treatments
patients.